James Cummings
Chief Tech/Sci/R&D Officer bei VAXART, INC.
Vermögen: 424 841 $ am 31.03.2024
Profil
James F.
Cummings is currently the Chief Medical Officer at Vaxart, Inc. Prior to this, he served as the President & CEO at ICON Government & Public Health Solutions, Inc. from 2018 to 2021.
He also held positions as Director at OyaGen, Inc., Director-Translational Medicine at Walter Reed Army Institute of Research from 2007 to 2009, Director-Defense Department at Global Emerging Infectious Surveillance & Response System from 2012 to 2015, and VP-Clinical Development & Translational Medicine at Novavax, Inc. from 2015 to 2018.
Cummings received his undergraduate degree from Georgetown University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC.
0,19% | 28.03.2024 | 326 801 ( 0,19% ) | 424 841 $ | 31.03.2024 |
Aktive Positionen von James Cummings
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXART, INC. | Chief Tech/Sci/R&D Officer | 27.09.2021 |
Ehemalige bekannte Positionen von James Cummings
| Unternehmen | Position | Ende |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Chief Executive Officer | 01.09.2021 |
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
| Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01.08.2015 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | 01.03.2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Director/Board Member | - |
Ausbildung von James Cummings
| Georgetown University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology OyaGen, Inc. operates as a biotechnology company. It offers anti Human Immunodeficiency Virus (HIV) drug that solves the problems of viral resistance. The company was founded by Harold Smith in September 2003 and is headquartered in Henrietta, NY. | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Government & Public Health Solutions, Inc. operates as a full service Contract Research Organization (CRO) specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. Its services include project, program, and data management; clinical monitoring; regulatory and medical affairs; and safety oversight and pharmacovigilance. The company was founded by Victoria Tifft in 1994 and is headquartered in Hinckley, OH. | Commercial Services |
| Walter Reed Army Institute of Research | |
| Global Emerging Infectious Surveillance & Response System |
